Evidence map›Paper›PMID 42400889›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Autonomously Motile Nano-PROTACs Act as Protein-Sweeping Robots to Enhance Targeted Protein Degradation.

Xiang Lu, Furui Qiu, Huijie Liang, Xiaomin Wang, Meng Xue, Jianghao Wang, Jinjin Shi, Hongling Zhang, Binghua Wang

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiang LuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0001-6166-9881
Furui QiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Huijie LiangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Xiaomin WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Meng XueSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Jianghao WangHangzhou Matridx Biotechnology Co. Ltd., Hangzhou, China.
Jinjin ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0003-1531-7265
Hongling ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0009-0009-7620-3609
Binghua WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.

Funding

National Natural Science Foundation of China 82173784National Natural Science Foundation of China 82203065National Natural Science Foundation of China 82473863National Natural Science Foundation of China U25A20180National Natural Science Foundation of Henan 252300421353State Key Laboratory of Metabolic Dysregulation &Prevention and Treatment of Esophageal Cancer。 2025SGAQZ-MS-04
6 · The paper itself

Abstract

Although nanoparticle-based PROTACs (nPROs) provide a modular strategy to improve the biological fate of PROTACs, their degradation performance was fundamentally limited by restricted intracellular diffusivity. Here, we introduced an unconventional solution: Imparting autonomous motility to nPROs to transform them from passive carriers into active protein-seeking degraders. We engineered nano-motoring PROTACs (nMPROs) through asymmetric modification of gold nanoparticles, displaying POI ligands and E3 recruiters on one hemisphere while anchoring catalase on the opposite hemisphere. Within the H

Indexed as

Metal NanoparticlesAutonomous RobotsCatalaseGoldHumansLigandsProteolysisProteolysis Targeting ChimeraCatalaseGoldLigandsProteolysis Targeting Chimerahook effectsproteolysis‐targeting chimerasself‐propelling nanoplatformtarget protein degradation

Identifiers

PMID42400889
PMCPMC13449120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.